Eclosion SA
Europe, Geneve, Switzerland, Geneva
Description
Eclosion assists entrepreneurs with the necessary resources to bridge the gap between their laboratories and the stage where the start-up
Investor Profile
Eclosion SA has backed more than 16 startups, with 0 new investments in the last 12 months alone. The firm has led 9 rounds, about 56% of its total and boasts 6 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Seed, Series C, Post Ipo Equity rounds (top funding stages).
- Majority of deals are located in Switzerland.
- Strong thematic focus on Biotechnology, Pharmaceutical, Health Care.
Stage Focus
- Seed (69%)
- Series C (13%)
- Post Ipo Equity (6%)
- Convertible Note (6%)
- Series Unknown (6%)
Country Focus
- Switzerland (100%)
Industry Focus
- Biotechnology
- Pharmaceutical
- Health Care
- Medical
- Life Science
- Therapeutics
- Consulting
- Genetics
- Business Development
- Funding Platform
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
